D. Shabat et al.
Synthesis of first-generation self-immolative dendritic molecule 1
80.2, 78.8, 72.0, 59.9, 46.4, 46.1, 36.4, 35.9, 35.1, 29.8, 28.3, 25.7, 18.2,
À5.5 ppm; MS (FAB): m/z: 700.4 [M+Na]+.
Compound 7: Commercially available 4-hydroxybenzoic acid (2.0 g,
14.5 mmol) was dissolved in DMF (10 mL) before N-(3-dimethylamino-
propyl)-N’-ethylcarbodiimide (EDC) (3.3 g, 17.4 mmol), 1-hydroxybenzo-
triazole (HOBT) (1.0 g, 7.3 mmol), and propargylamine (1.0 mL,
14.5 mmol) were added. The mixture was stirred overnight and moni-
tored byTLC (EtOAc/He x 2:3). Upon completion of the reaction, the
solvent was removed under reduced pressure. The crude product was pu-
rified byusing column chromatographyon silica gel (EtOAc/Hex 2:3) to
give 7 as a yellowish oil (1.8 g, 70%). 1H NMR (200 MHz, CDCl3): d=
7.70 (d, J=6.8 Hz, 2H), 6.81 (d, J=6.8 Hz, 2H), 4.11 (d, J=2.5 Hz, 2H),
2.71 ppm (t, J=2.5 Hz, 1H); 13C NMR (100 MHz, CDCl3): d=167.9,
160.6, 128.8, 124.4, 114.5, 79.5, 70.3, 28.3 ppm; MS (FAB): m/z: 176.0
[M+H]+.
Compound 12: Compound 11 (1.5 g, 2.2 mmol) was dissolved in MeOH
(10 mL) and Amberlyst-15 was added. The reaction was stirred at RT for
2 h and monitored byTLC (EtOAc). Upon completion of the reaction,
the solution was filtered to remove Amberlyst-15 and the solvent was re-
moved under reduced pressure. The crude product was purified byusing
column chromatographyon silica gel (EtOAc/MeOH 19:1) to give 12 as
a white solid (500 mg, 56%). 1H NMR (200 MHz, CD3OD): d=7.78 (s,
2H), 4.57 (brs, 4H), 4.25–4.23 (m, 2H), 3.60–3.40 (m, 4H), 3.20 (s, 2H),
3.10 (s, 1H), 2.96 (s, 3H), 2.40 (brs, 1H), 1.59–1.54 ppm (m, 9H);
13C NMR (100 MHz, CD3OD): d=169.8, 158.9, 157.5, 152.1, 134.1, 130.3,
130.0, 83.2, 83.0, 74.4, 62.5, 50.3, 49.0, 38.7, 37.9, 37.6, 31.3 ppm; HRMS
(MALDI-TOF): m/z calcd for C22H31N3O7: 472.2015; found: 472.2059
[M+Na]+.
Compound 8: Compound 7 (1.8 g, 10.2 mmol) was added to a cold (08C)
12% aqueous NaOH (12 mL) solution. The mixture was kept at 08C and
formaldehyde (37% in water; 10 mL) was added. The reaction was stir-
red at 558C for 3 d and monitored byTLC (EtOAc/MeOH 95:5). Upon
completion of the reaction, the solution was diluted with EtOAc and
washed with saturated ammonium chloride solution. The aqueous layer
was washed twice with EtOAc. The combined organic layer was dried
over MgSO4 and the solvent was removed under reduced pressure. The
crude product was purified byusing column chromatographyon silica gel
(EtOAc/MeOH 19:1) to give 8 as a white solid (1.9 g, 80%). 1H NMR
(200 MHz, CD3OD): d=7.80 (s, 2H), 4.91 (s, 4H), 4.26 (d, J=2.5 Hz,
2H), 2.70 ppm (t, J=2.5 Hz, 1H); 13C NMR (100 MHz, CD3OD): d=
168.1, 156.7, 126.8, 126.0, 124.4, 79.4, 70.2, 60.3, 28.3 ppm; MS (FAB):
m/z: 236.0 [M+H]+.
Compound 13: Compound 12 (300 mg, 0.67 mmol) was dissolved in dry
THF (6 mL) and was cooled to 08C before diisopropyl ethyleneamine
(DIPEA) (945 mL, 5.4 mmol) followed by p-nitrophenyl chloroformate
(800 mg, 4.0 mmol) and pyridine (27 mL, 0.33 mmol) were added. The re-
action was allowed to warm to RT and was monitored byTLC (EtOAc/
Hex 3:1). Upon completion of the reaction, the solution was diluted with
EtOAc and washed with satACHTERuUNG rated aqueous NH4Cl and NaHCO3 solu-
tions. The organic layer was dried over MgSO4 and the solvent was re-
moved under reduced pressure. The crude product was purified byusing
column chromatographyon silica gel (EtOAc/Hex 7:3) to give 13 as a
white solid (430 mg, 82%). 1H NMR (200 MHz, CDCl3): d=8.23 (d, J=
9.0 Hz, 4H), 7.94 (s, 2H), 7.34 (d, J=9.0 Hz, 4H), 5.28 (s, 4H), 4.23 (m,
2H), 3.62–3.43 (m, 4H), 3.18–3.00 (m, 3H), 2.92–2.83 (m, 3H), 2.27 (brs,
1H), 1.45–1.42 ppm (m, 9H); 13C NMR (100 MHz, CDCl3): d=166.2,
156.6, 154.1, 153.1, 146.3, 132.9, 130.4, 130.0, 126.1, 122.6, 122.5, 80.8,
78.9, 73.0, 66.2, 48.5, 47.8, 46.8, 36.1, 35.6, 30.7, 29.2 ppm; HRMS
(MALDI-TOF): m/z calcd for C36H37N5O15: 802.2178; found: 802.2112
[M+Na]+.
Compound 9: Compound 8 (713 mg, 3.0 mmol) was dissolved in DMF
(10 mL) and cooled to 08C before imidazole (408 mg, 6.0 mmol) and
TBS-Cl (910 mg, 6.0 mmol) were added. The reaction was stirred at RT
for 2 h and monitored byTLC (EtOAc/Hex 2:8). Upon completion of
the reaction, the solution was diluted with diethyl ether and washed with
saturated ammonium chloride solution. The organic layer was dried over
MgSO4 and the solvent was removed under reduced pressure. The crude
product was purified byusing column chromatographyon silica gel
(EtOAc/Hex 15:85) to give 9 as a colorless oil (1.12 g, 80%). 1H NMR
(400 MHz, CDCl3): d=7.57 (s, 2H), 4.87 (s, 4H), 4.23 (dd, J=5.0, 2.5 Hz,
2H), 2.17 (t, J=2.5 Hz, 1H), 0.95 (s, 18H), 0.13 ppm (s, 12H); 13C NMR
(100 MHz, CDCl3): d=166.7, 156.4, 126.1, 124.5, 79.6, 71.7, 62.7, 29.6,
25.8, 25.6, 18.2, À5.5 ppm; MS (FAB): m/z: 464.2 [M+H]+.
Compound 10: Compound 9 (1.12 g, 2.4 mmol) was dissolved in dryTHF
(20 mL) before NEt3 (1.0 mL, 7.2 mmol) was added and the mixture was
cooled to 08C. p-Nitrophenyl chloroformate (581 mg, 2.9 mmol) dissolved
in dryTHF (10 mL) was then added dropwise before the reaction was
stirred for 1 h at RT and was monitored byTLC (EtOAc/Hex 2:8). Upon
completion of the reaction, the solution was filtered, the solvent was
evaporated, and the crude product was purified byusing column chroma-
tographyon silica gel (EtOAc/Hex 15:85) to give 10 as a colorless oil
(1.35 g, 90%). 1H NMR (200 MHz, CDCl3): d=8.43 (d, J=8.1 Hz, 2H),
8.02 (s, 2H), 7.63 (d, J=8.1 Hz, 2H), 7.01 (m, 1H), 4.91 (s, 4H), 4.38 (dd,
J=2.5, 2.6 Hz, 2H), 2.41 (t, J=2.5 Hz, 1H), 1.08 (s, 18H), 0.29 ppm (s,
12H); 13C NMR (100 MHz, CDCl3): d=166.4, 155.2, 149.4, 147.7, 145.5,
133.9, 132.2, 126.3, 125.3, 121.5, 79.2, 71.8, 60.3, 31.5, 25.8, 18.2,
À5.5 ppm; HRMS (MALDI-TOF): m/z calcd for C31H44N2O8Si2:
651.2528; found: 651.2562 [M+Na]+.
Compound 14: Compound 13 (430 mg, 0.55 mmol) was dissolved in
DMF (2 mL) before 6-aminoquinoline (320 mg, 2.2 mmol), a catalytic
amount of HOBT (5 mg), and DIPEA (240 mL, 1.4 mmol) were added.
The reaction was heated to 508C, stirred overnight, and monitored by
TLC (MeOH/EtOAc 1:9). Upon completion of the reaction, the solvent
was removed under reduced pressure. The crude product was purified by
using column chromatographyon silica gel (MeOH/EtOAc 2:8) to give
1
14 as a white solid (270 mg, 62%). H NMR (200 MHz, CDCl3): d=8.69–
8.67 (m, 2H), 7.98–7.88 (m, 8H), 7.54–750 (m, 2H), 7.25–7.22 (m, 2H),
5.08 (brs, 4H), 4.13 (s, 2H), 3.52–3.36 (m, 4H), 3.05–2.76 (m, 6H), 2.17
(brs, 1H), 1.38–1.30 ppm (m, 9H); 13C NMR (100 MHz, CDCl3): d=
166.8, 154.4, 154.1, 149.8, 149.7, 145.9, 137.0, 136.3, 132.3, 131.1, 130.9,
129.9, 129.6, 123.4, 122.3, 114.8, 81.2, 80.1, 72.7, 63.3, 47.6, 46.4, 36.6, 35.2,
30.6, 29.2 ppm; HRMS (MALDI-TOF): m/z calcd for C42H43N7O9:
812.3061; found: 812.3014 [M+Na]+.
Compound 16: Compound 14 (64 mg, 0.08 mmol) was dissolved in TFA
(1 mL) and stirred for few minutes before the excess acid was removed
under reduced pressure and the crude amine salt was dissolved in DMF
(0.5 mL). Compound 15[13] (53 mg, 0.08 mmol) and NEt3 (0.1 mL) were
then added, and the reaction was monitored byTLC (MeOH/CH 2Cl2
1:9). Upon completion of the reaction, the solvent was removed under
reduced pressure. The crude product was purified byusing column chro-
matographyon silica gel (MeOH/EtOAc 1:9) to give 16 as a white solid
(45 mg, 46%). 1H NMR (200 MHz, CDCl3): d=8.85–8.55 (m, 2H), 8.10–
7.80 (m, 10H), 7.67–7.45 (m, 2H), 7.29–6.71 (m, 14H), 5.09–5.01 (m,
6H), 4.13–4.05 (m, 2H), 3.67–3.30 (m, 16H), 3.04–2.90 (m, 6H), 2.23 ppm
(s, 1H); 13C NMR (100 MHz, CDCl3): d=172.1, 166.5, 155.3, 153.7, 153.5,
150.9, 148.9, 145.0, 136.6, 135.8, 135.0, 133.6, 103.7, 130.5, 130.2, 129.9,
129.4, 129.3, 129.0, 128.9, 128.8, 128.5, 127.3, 122.9, 121.8, 121.7, 80.0,
71.9, 71.8, 62.2, 53.6, 48.5, 43.6, 38.8, 32.1, 31.7, 30.0, 29.8 ppm; HRMS
(MALDI-TOF): m/z calcd for C66H64N10O13: 1227.4547; found: 1227.4656
[M+Na]+.
Compound 11: Compound 10 (1.5 g, 2.3 mmol) was dissolved in DMF
(7 mL). Previouslydescribed mono-Boc-protected N,N’-dimethylethyl-
ACHTREUNGeneACHTREUNG
diamine[3] (541 mg, 2.9 mmol) was added. The reaction was stirred at
RT for 1 h and monitored byTLC (EtOAc/Hex 1:1). Upon completion
of the reaction, the solvent was removed under reduced pressure and the
crude product was purified byusing column chromatographyon silica gel
(EtOAc/Hex 2:8) to give 11 as a colorless oil (1.45 g, 90%). 1H NMR
(400 MHz, CDCl3): d=7.79 (s, 2H), 6.32 (m, 1H), 4.68–4.67 (m, 4H),
4.27–4.25 (m, 2H), 3.61–3.43 (m, 4H), 3.24 (s, 2H), 3.12 (s, 1H), 2.96 (s,
3H), 2.32 (brs, 1H), 1.51–1.46 (m, 9H), 0.92 (s, 18H), 0.08 ppm (s, 12H);
13C NMR (100 MHz, CDCl3): d=167.2, 153.1, 153.0, 134.6, 130.8, 125.1,
Compound 1: Compound 16 (16 mg, 0.013 mmol) was dissolved in DMF
(0.5 mL) before PEG-400 azide (6.3 mg, 0.016 mmol), copper sulfate
(2 mg, 0.013 mmol), and TBTA (7.5 mg, 0.0133 mmol) were added. Final-
818
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2007, 13, 812 – 821